🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open-label study to evaluate the safety and efficacy of an antic...
Status
Unknown
Location
Multiple Locations
Start Date
2018-04
Trial ID
NCT03472352
Treatments Being Tested
1. To investigate and compare the affective short-term effects of opioid dr...
Status
Completed
Location
Harald Lenz
Start Date
2022-12-13
Trial ID
NCT05639712
This is an open-label study to evaluate the safety and efficacy of an antic...
Status
Unknown
Location
Multiple Locations
Start Date
2018-04
Trial ID
NCT03474861
Treatments Being Tested
This is a phase 2 trial investigating the effect and safety of afatinib in ...
Status
Unknown
Location
Peking University Cancer Hospital and Institute
Start Date
2019-04-28
Trial ID
NCT03940976
Treatments Being Tested
This is a multicenter, open labeled, phase 2 clinical trial, where patients...
Status
Active Not Recruiting
Location
Haukeland University Hospital
Start Date
2016-10
Trial ID
NCT02965950
Treatments Being Tested
This is a prospective, randomized, open-label phase III clinical study on t...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2023-06-01
Trial ID
NCT05891093
Treatments Being Tested
Multiple sclerosis (MS) is a neurological condition which is a common cause...
Status
Completed
Location
Department of Neuroinflammation, UCL Institute of Neurology
Start Date
2019-05-16
Trial ID
NCT03896217
Treatments Being Tested
Subjects with at least two teeth with dentinal hypersensitivity and who mee...
Status
Completed
Location
Multiple Locations
Start Date
2016-10
Trial ID
NCT02789618
Background: The National Cancer Institute (NCI) Surgery Branch has develop...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2014-07-03
Trial ID
NCT02153905
The purpose of study is to evaluate if the addition of GSK3359609 to pembro...
Status
Terminated
Location
GSK Investigational Site
Start Date
2019-11-21
Trial ID
NCT04128696
Treatments Being Tested